APOBEC3B and cancer: Additionally, RNA-independent protein–protein interactions have been observed, particularly between APOBEC3B and prefoldin 5 (PFD5), which inhibit the PFD5-mediated-degradation of the oncogene cMyc, suggesting a role for APOBEC3B in cancer pathways [26].